HOW did GLP-1RAs bring about a paradigm shift in the guidelines of managing T2DM: A path to gluco-cardio Centricity by P.P. Mohanan, Pankaj Jariwala

Subjects: Get full text

Effectiveness of GLP1-RAs in type 2 diabetes: a gender analysis by Alessandro Cuttone, Annalisa Giandalia, Andrea Muscarà, Letterio Giorgianni, Carmela Morace, Giovanni Squadrito, Domenico Cucinotta, Giuseppina Russo

Subjects: “…type 2 diabetes, glp1-ras, gender differences…”
Get full text

Therapeutic advances in obesity management: an overview of the therapeutic interventions by Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, Jenna Abu-Farha, Rayan Al-Harris, Aishwarya Mariam Ambi, Mohammed Altigani Abdalla, Mohammed Altigani Abdalla, Fahd Al-Mulla, Mohamed Abu-Farha, Mohamed Abu-Farha, Jehad Abubaker

Subjects: Get full text

The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review by Ioanna Daniilopoulou, Eugenia Vlachou, George I. Lambrou, Anastasia Ntikoudi, Eleni Dokoutsidou, Georgia Fasoi, Ourania Govina, Anna Kavga, Athanasios N. Tsartsalis

Subjects: Get full text

Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review by Janelle Duah, David B. Seifer

Subjects: Get full text

Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized c... by Sijin Wu, Wenzhao Lu, Zhongli Chen, Yan Dai, Keping Chen, Shu Zhang

Subjects: “…GLP-1 RAs…”
Get full text

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database by Wenchao Lu, Shihan Wang, Huilin Tang, Tao Yuan, Wei Zuo, Yuling Liu

Subjects: Get full text

Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies by Deqiang Zheng, Ning Li, Rui Hou, Xiaoyu Zhang, Lijuan Wu, Jan Sundquist, Kristina Sundquist, Jianguang Ji

Subjects: “…GLP-1 RAs…”
Get full text

The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study by Salvatore Greco, Vincenzo M. Monda, Giorgia Valpiani, Nicola Napoli, Carlo Crespini, Fabio Pieraccini, Anna Marra, Angelina Passaro

Subjects: Get full text

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus by Xu He, Xu He, Xu He, Wei Zhao, Wei Zhao, PeiHang Li, PeiHang Li, YinJiang Zhang, YinJiang Zhang, GuoHua Li, HongYu Su, BiNan Lu, BiNan Lu, ZongRan Pang, ZongRan Pang

Subjects: Get full text

Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born? by Dalgisio Lecis, Francesca Romana Prandi, Lucy Barone, Martina Belli, Domenico Sergi, Susanna Longo, Saverio Muscoli, Francesco Romeo, Massimo Federici, Stamatios Lerakis, Francesco Barillà

Subjects: “…GLP-1RAs…”
Get full text

A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review by Mariana Cornelia Tilinca, Robert Aurelian Tiuca, Alexandru Burlacu, Andreea Varga

Subjects: Get full text

Case report: GLP1RA for the treatment of diabetes in liver transplanted people. Do they increase the risk of pancreatitis? by Valeria Grancini, Irene Cogliati, Alessia Gaglio, Veronica Resi, Emanuela Orsi

Subjects: “…GLP1RAs…”
Get full text

The Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists in the Standard of Care Treatment of Type 2 Diabetes Mellitus by Teodor Salmen, Florin-Teodor Bobirca, Ioana-Cristina Bica, Doina-Andrada Mihai, Corina Pop, Anca Pantea Stoian

Subjects: Get full text

Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis by Ligang Liu, Hekai Shi, Yufei Shi, Anlin Wang, Nuojin Guo, Heqing Tao, Milap C. Nahata

Subjects: “…GLP-1RAs…”
Get full text

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential by Tohada M. AL-Noshokaty, Rehab Abdelhamid, Nourhan M. Abdelmaksoud, Aya Khaled, Mariam Hossam, Razan Ahmed, Toka Saber, Shahd Khaled, Shereen Saeid Elshaer, Ahmed I. Abulsoud

Subjects: Get full text

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity by Andrew Overholser, Eric Czech, Linda Speer, Joel Wilson, Alex Overholser

Subjects: “…GLP-1RAs…”
Get full text

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality by Mei Qiu, Xu-Bin Wei, Wei Wei

Subjects: “…GLP1Ras…”
Get full text

GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway by Alessio Mazzieri, Giuseppe Basta, Riccardo Calafiore, Riccardo Calafiore, Giovanni Luca, Giovanni Luca

Subjects: Get full text

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials by Xu Zhao, Kun Huang, Meijie Zheng, Junting Duan

Subjects: Get full text